<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s13099-019-0317-6</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">13099</journal-id><journal-title-group><journal-title>Gut Pathogens</journal-title><abbrev-journal-title abbrev-type="publisher">Gut Pathog</abbrev-journal-title></journal-title-group><issn pub-type="epub">1757-4749</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s13099-019-0317-6</article-id><article-id pub-id-type="manuscript">317</article-id><article-id pub-id-type="doi">10.1186/s13099-019-0317-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Recombinant fusion protein of Heparin-Binding Hemagglutinin Adhesin and Fibronectin Attachment Protein (rHBHA-FAP) of <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> elicits a strong gamma interferon response in peripheral blood mononuclear cell culture</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Eraghi</surname><given-names>Vida</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au2"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1878-1103</contrib-id><name><surname>Derakhshandeh</surname><given-names>Abdollah</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs1309901903176_cor2">b</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Hosseini</surname><given-names>Arsalan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Haghkhah</surname><given-names>Masoud</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Sechi</surname><given-names>Leonardo A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Motamedi Boroojeni</surname><given-names>Azar</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0745 1259</institution-id><institution-id institution-id-type="GRID">grid.412573.6</institution-id><institution content-type="org-division">Department of Pathobiology, School of Veterinary Medicine</institution><institution content-type="org-name">Shiraz University</institution></institution-wrap><addr-line content-type="postcode">71345-1731</addr-line><addr-line content-type="city">Shiraz</addr-line><country country="IR">Iran</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2097 9138</institution-id><institution-id institution-id-type="GRID">grid.11450.31</institution-id><institution content-type="org-division">Sezione di Microbiologia e Virologia, Dipartimento di Scienze Biomediche</institution><institution content-type="org-name">Università degli Studi di Sassari</institution></institution-wrap><addr-line content-type="postcode">07100</addr-line><addr-line content-type="city">Sassari</addr-line><country country="IT">Italy</country></aff></contrib-group><author-notes><corresp id="IDs1309901903176_cor2"><label>b</label><phone>+98-7136138666</phone><email>drkhshnd77@gmail.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>9</day><month>7</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>11</volume><issue seq="36">1</issue><elocation-id>36</elocation-id><history><date date-type="registration"><day>4</day><month>7</month><year>2019</year></date><date date-type="received"><day>9</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>4</day><month>7</month><year>2019</year></date><date date-type="online"><day>9</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s) 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1"><italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> (MAP) is a causative agent of Johne’s disease in all ruminants worldwide. Economic problems in dairy cattle and sheep industries, public health concern, persistence of MAP in the environment and lack of effective vaccines mentioned necessity of research about various antigens to introduce as vaccine candidates. Based on MAP pathogenesis, it seems that research about the production of new recombinant proteins to stimulate cell-mediated immunity is helpful. This study describes successful expression and purification of a chimeric fusion protein which consists of Heparin-Binding Hemagglutinin Adhesin (HBHA) and high antigenic region of Fibronectin Attachment Protein (FAP-P). Triggered antigen-specific IFN-γ response of isolated PBMCs from immunized goats to rHBHA-FAP and all crude proteins of MAP (PPD), was measured by ELISA.</p></sec><sec id="ASec2"><title>Results</title><p id="Par2">Significant increases were observed in the IFN-γ production level of peripheral blood mononuclear cells (PBMCs) stimulated by constructed chimeric protein from rHBHA-FAP and PPD vaccinated goats. Antigen-specific gamma interferon (IFN-γ) secretion in positive group (immunized by PPD) against rHBHA-FAP and test group (immunized by rHBHA-FAP) against PPD, also statistically insignificant rises between stimulation with rHBHA-FAP and PPD, suggested the potential and specificity of our chimeric protein to stimulate cell mediated immunity against MAP.</p></sec><sec id="ASec3"><title>Conclusions</title><p id="Par3">Collectively, these results demonstrate that rHBHA-FAP elicits a strong IFN-γ production in PBMC culture. Therefore, further studies of the present product as a candidate vaccine in naturally infected animals should be conducted, to analyze its potential.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic></kwd><kwd>Johne’s disease</kwd><kwd>Chimeric protein</kwd><kwd>PBMC</kwd><kwd>IFN-γ</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>School of Veterinary Science, Shiraz University</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100009587</institution-id></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>7</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/13099_2019_Article_317.pdf</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Medicine &amp; Public Health</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Gastroenterology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Medical Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Parasitology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Medicine</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par4">The causative agent of Johne’s disease in all ruminant species worldwide is <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> (MAP). Chronic untreatable granulomatous enteritis in Johne’s disease leads to economic problems in dairy cattle and sheep industries that result in decreased milk, diarrhea, and weight loss [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par5">Although, MAP as a zoonotic pathogen has not yet been confirmed, there is some investigations about the role of MAP in public health concern. MAP can be isolated from pasteurized milk [<xref ref-type="bibr" rid="CR3">3</xref>], children’s milk powder [<xref ref-type="bibr" rid="CR4">4</xref>], soil and surface water [<xref ref-type="bibr" rid="CR5">5</xref>]. Also, MAP may shed through infected animal’s feces and survive in the environment for a long period. Then the exposure of human to a contaminated environment is a potential risk [<xref ref-type="bibr" rid="CR6">6</xref>]. There are studies about the association of MAP with Crohn’s disease [<xref ref-type="bibr" rid="CR7">7</xref>], sarcoidosis and Blau syndrome [<xref ref-type="bibr" rid="CR8">8</xref>], type 1 diabetes [<xref ref-type="bibr" rid="CR9">9</xref>], Hashimoto’s thyroiditis [<xref ref-type="bibr" rid="CR10">10</xref>], and multiple sclerosis (MS) [<xref ref-type="bibr" rid="CR11">11</xref>]. This could explain the significant risk of MAP to public health safety. Among the approaches to reduce Johne’s disease in most countries, testing and culling practices are the most common [<xref ref-type="bibr" rid="CR12">12</xref>], but vaccination is the best control strategy and more cost-effective [<xref ref-type="bibr" rid="CR13">13</xref>] than other approaches. Whole-cell based vaccines, live attenuated vaccines, and inactivated vaccines were have been used until now [<xref ref-type="bibr" rid="CR12">12</xref>] with inadequate protection. <italic>M. avium</italic> subsp. <italic>paratuberculosis</italic> binds to Microfold cells (M cells) and epithelial cells through a fibronectin bridge and mycobacterial adhesins, to cross the intestinal barrier and enter into the subepithelium. Then, MAP can be picked up by antigen presenting cells and carried to regional lymph nodes [<xref ref-type="bibr" rid="CR14">14</xref>]. IFN-γ induced by Th<sub>1</sub>-mediated immune responses are play a crucial role in activating macrophages to kill intracellular MAP and protection against MAP infection [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Gamma interferon (IFN-γ) response and antibody response can be induced by MAP. IFN-γ responses (mediated by Th<sub>1</sub>) detected early can lead to the controlling of MAP replication and restricted bacterial shedding; but antibody responses (mediated by Th<sub>2</sub>) detected late in infection which inhibit Th<sub>1</sub> and are much less effective against MAP [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. The best characterized mycobacterial adhesin is Heparin-binding hemagglutinin (HBHA). HBHA is located on the surface of mycobacteria and is important in the binding of mycobacteria to the epithelial cells [<xref ref-type="bibr" rid="CR19">19</xref>] during bovine tuberculosis and Johne’s disease; it is also a major target for host humoral immune response. Some studies have demonstrated that methylated HBHA causes specific IFN-γ response in latent <italic>M. tuberculosis</italic> infection [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Also, there is some reports about the induction by HBHA of both CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes producing cytokines like IFN-γ in <italic>M. tuberculosis</italic> infection [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. The FN-binding glycoprotein family including fibronectin attachment proteins (FAPs) is important for attachment and internalization of MAP by epithelial cells and induce Th<sub>1</sub> polarization and IFN-γ production in vitro [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par6">Due to the global distribution of paratuberculosis and the creation of many economic problems, as well as suspicion of zoonotic nature of the MAP, using control strategies and research to identify appropriate antigens and introduce them as vaccine candidates are important. This study describes successful expression, purification, and evaluation of cellular immune response induction ability of a chimeric fusion protein which consists of HBHA and high antigenic region of FAP-P. Triggered antigen-specific IFN-γ response of isolated PBMCs from immunized goats (with our chimeric fusion protein and the crude protein fraction prepared from the culture supernatant of MAP-PPD) to rHBHA-FAP and PPD, was measured by ELISA.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Plasmid construction and cloning</title><p id="Par7">The designed chimeric gene consists of the HBHA-coding sequence, (Pro Glu)<sub>7</sub> as a linker, and high antigenic region of FAP-P (amino acid 125 to 205) was synthesized and inserted in pUC57 between restriction sites of <italic>Eco</italic>RI and <italic>Hin</italic>dIII by GenScript company (USA). The transformation and propagation of the plasmid in <italic>E. coli</italic> DH5α was done successfully.</p></sec><sec id="Sec4"><title>Successful expression and purification of rHBHA-FAP in <italic>E. coli</italic> BL21 (DE3)</title><p id="Par8">The fusion gene was successfully subcloned into the pET26b, transformed into <italic>E. coli</italic> BL21 (DE3), and confirmed by colony PCR. The expression of the chimeric protein is shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. The desired fusion protein was determined in the medium induced by 1 mM IPTG at 37 °C after 4 h of induction and the expected size of ~ 35 kDa was obtained. Expression levels after overnight incubation or increasing IPTG did not increase significantly. Using monoclonal anti-polyhistidine-peroxidase, the desired band obtained was confirmed to be the HBHA-FAP chimeric protein by immunoblotting (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>SDS-PAGE (<bold>a</bold>) and western blot (<bold>b</bold>) of chimeric rHBHA-FAP. <bold>a</bold> Running samples on 12% SDS-PAGE gel for choosing optimum temperature of rHBHA-FAP expression in <italic>E. coli</italic>. Lane M: protein ladder (CinnaGen PR911654 [SL7012]), lane 1: negative control, lane 2: expression at 30 °C, lane 3: expression at 37 °C. The white arrow indicates our desired band. <bold>b</bold> Western blot analysis using HRP-anti-polyhistidine. Lanes 1, 2 and 3: rHBHA-FAP with the expected size of ~ 35 kDa, lane 4: negative control</p></caption><p><graphic specific-use="HTML" mime-subtype="JPEG" xlink:href="MediaObjects/13099_2019_317_Fig1_HTML.jpg" id="MO1"/></p></fig></p><p id="Par9">Binding of polyhistidine-tagged proteins with resin was performed using Ni–NTA column (Qiagen) and desired chimeric protein was then passed over the column with elution buffer. Using imidazole in binding buffer reduced the number of proteins that bind nonspecifically to the resin; also, using Tween and 2-mercaptoethanol reduced the background signals. Purified fractions were run on a 12% SDS-PAGE gel as to check the purity of the protein extracts.</p></sec><sec id="Sec5"><title>IFN-γ response</title><p id="Par10">Evaluation of cell mediated immune response to the chimeric protein was done by measuring antigen specific IFN-γ responses. The high level of secreted IFN-γ in supernatants of PBMCs in 96 h after incubation was detected. Therefore, the levels of secreted IFN-γ in 96 h after incubation were recorded in the charts. The highest level of IFN-γ was measured in supernatants of PBMCs stimulated by PHA in all groups, which indicates the ability of stimulated T-calls to secrete significant high level of IFN-γ.</p><p id="Par11">Although there was no significant difference in induction of IFN-γ by PPD and rHBHA-FAP within the control group (Fig. <xref rid="Fig2" ref-type="fig">2</xref>), levels of IFN-γ after the second booster was increased significantly in PBMCs isolated from PPD and rHBHA-FAP vaccinated goats stimulated with PPD and rHBHA-FAP (Figs. <xref rid="Fig3" ref-type="fig">3</xref>, <xref rid="Fig4" ref-type="fig">4</xref>). The response was further enhanced after the third and fourth booster in test group (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). The highest level of secreted IFN-γ of PBMCs stimulated with PPD was observed in week three (after second booster) in positive control group (Fig. <xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>The level of IFN-γ production in supernatants of PBMCs in control negative group. PBMCs were isolated from goats immunized with adjuvant only and stimulation of isolated PBMCs was done with PHA, rHBHA-FAP and PPD 96 h after incubation. PBMCs without stimulation in all groups were considered as control. The numbers of 1 to 5, refer to first to fifth bleeding. Error bars represent standard error of the mean (SEM) between the three replicates</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13099_2019_317_Fig2_HTML.png" id="MO2"/></p></fig><fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>The level of IFN-γ production in supernatants of PBMCs in control positive group. PBMCs were isolated from goats immunized with PPD + adjuvant 1:1 (v/v) and stimulation of isolated PBMCs was done with PHA, rHBHA-FAP and PPD 96 h after incubation. PBMCs without stimulation in all groups were considered as control. The numbers of 1 to 5, refer to first to fifth bleeding. Error bars represent standard error of the mean (SEM) between the three replicates. *A statistically significant change as compared to the control of the same group at <italic>p </italic>&lt; 0.05. **A statistically significant difference between stimulated PBMCs by PPD and rHBHA-FAP at <italic>p </italic>&lt; 0.05</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13099_2019_317_Fig3_HTML.png" id="MO3"/></p></fig><fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>The level of IFN-γ production in supernatants of PBMCs in test group. PBMCs were isolated from goats immunized with rHBHA-FAP + adjuvant 1:1 (v/v) and stimulation of isolated PBMCs was done with PHA, rHBHA-FAP and PPD 96 h after incubation. PBMCs without stimulation in all groups were considered as control. The numbers of 1 to 5, refer to first to fifth bleeding. Error bars represent standard error of the mean (SEM) between the three replicates. *A statistically significant change as compared to the control of the same group at <italic>p </italic>&lt; 0.05. **A statistically significant difference between stimulated PBMCs by PPD and rHBHA-FAP at <italic>p </italic>&lt; 0.05</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13099_2019_317_Fig4_HTML.png" id="MO4"/></p></fig></p><p id="Par12">In test group, statistically significant difference between stimulated PBMCs by PPD and rHBHA-FAP was observed just in week 5 (Fig. <xref rid="Fig4" ref-type="fig">4</xref>); but in control positive group, the differences of IFN-γ level was statistically significant after the first vaccination (week 2, 3, 4, and 5) (Fig. <xref rid="Fig3" ref-type="fig">3</xref>).</p></sec></sec><sec id="Sec6" sec-type="discussion"><title>Discussion</title><p id="Par13">Since MAP causes Johne’s disease with severe economic losses and zoonotical potential of the bacteria, control strategies are essential. Between control strategies, vaccination is the best [<xref ref-type="bibr" rid="CR13">13</xref>] and attempts have been made to introduce appropriate antigens as vaccine candidates. MAP is an intracellular bacterium that can infect macrophages. It is therefore expected to stimulate cell-mediated immunity and thus cooperate in preventing disease progression [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Then, research about the production of new recombinant proteins, evaluation of capability to IFN-γ response induction, and immunization assay are helpful. Several proteins and several antigens were introduced as vaccine candidates and some of them were tested for their potential impact [<xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. In addition, several antigens have been reported as potent inducer of IFN-γ production, including the secreted 14-kDa protein MPP14 [<xref ref-type="bibr" rid="CR33">33</xref>], alkyl hydroperoxidase reductase C (AhpC) and AhpD [<xref ref-type="bibr" rid="CR30">30</xref>], the 30-kDa antigen P30 [<xref ref-type="bibr" rid="CR34">34</xref>], a superoxide dismutase [<xref ref-type="bibr" rid="CR35">35</xref>], the 85B antigen [<xref ref-type="bibr" rid="CR36">36</xref>], a thiol peroxidase [<xref ref-type="bibr" rid="CR37">37</xref>], MAP10, MAP39 and MAP41 [<xref ref-type="bibr" rid="CR29">29</xref>] MAP1305 [<xref ref-type="bibr" rid="CR38">38</xref>], Ag85 [<xref ref-type="bibr" rid="CR39">39</xref>], CobT (35-kDa protein) [<xref ref-type="bibr" rid="CR40">40</xref>], 70 kDa heat shock protein [<xref ref-type="bibr" rid="CR41">41</xref>] and malate dehydrogenase [<xref ref-type="bibr" rid="CR42">42</xref>]. HBHA and FAP have two crucial roles in Mycobacteria: attachment and induction of cell-mediated immunity. HBHA protein has the capability of delivering the fusion protein through surface receptors on mammalian intestinal epithelial cells and Peyer’s Patches. The full length of FAP-P has been demonstrated to have the potential to induce cell-mediated immunity in vitro [<xref ref-type="bibr" rid="CR24">24</xref>] and in vivo [<xref ref-type="bibr" rid="CR43">43</xref>]. Some studies have demonstrated that methylated HBHA causes specific IFN-γ response in latent <italic>M. tuberculosis</italic> infection [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>] and the induction capability of both CD4<sup>+</sup> and CD8<sup>+</sup> lymphocytes in <italic>M. tuberculosis</italic> [<xref ref-type="bibr" rid="CR22">22</xref>]. Then, it was predicted that our chimeric protein can induce cell-mediated immunity.</p><p id="Par14">In the present study, successful expression and purification of the chimeric protein consisting of HBHA and high antigenic region of FAP-P, and evaluation of its IFN-γ response induction capability in PBMCs isolated from goat models, were primarily performed. To determine whether the goat immunized with the rHBHA-FAP could induce cell mediated immunity and respond to MAP, antigen specific IFN-γ responses were measured by ELISA. The highest level of IFN-γ was measured in supernatants of PBMCs stimulated by PHA, which indicates the ability of stimulated T-cells in secreting significant high level of IFN-γ.</p><p id="Par15">To check the specific response and level of secreted IFN-γ against rHBHA-FAP, immunization of goats with PPD was done to create memory T cell against all proteins of MAP.</p><p id="Par16">Stimulated PBMCs isolated from pre-immunized goats and control negative group (immunized with adjuvant only) by chimeric protein and PPD did not secrete IFN-γ using ELISA. The IFN-γ production level of isolated PBMCs from test group and stimulated by chimeric protein was significantly higher than the control of the same group. Also, the differences between the level of IFN-γ was not significant between PBMCs stimulated by PPD and rHBHA-FAP except in week five. These results showed the high antigenicity of our chimeric protein as compared to stimulation of cells by crude protein fraction prepared from the culture supernatant of MAP (PPD).</p><p id="Par17">The specificity of IFN-γ responses was confirmed by the significant rise in IFN-γ level after two booster injections of recombinant protein, the production of a high level of IFN-γ in PPD stimulated PBMCs isolated from rHBHA-FAP vaccinated group and the production of a high level of IFN-γ in rHBHA-FAP stimulated PBMCs isolated from PPD vaccinated group.</p><p id="Par18">Antigen-specific gamma interferon (IFN-γ) secretion in positive group (immunized by all crude proteins of MAP-PPD) against rHBHA-FAP, and test group (immunized by rHBHA-FAP) against PPD, also statistically insignificant rises between stimulation with rHBHA-FAP and PPD, suggested the potential and specificity of our chimeric protein to stimulate cell mediated immunity against MAP.</p></sec><sec id="Sec7" sec-type="conclusions"><title>Conclusions</title><p id="Par19">Collectively, our results showed that rHBHA-FAP protein is immunogenic in goats and it induces specific IFN-γ response. Therefore, because of the particularly high induction of cell-mediated immunity by this product, immunization studies of this product should be conducted as a vaccine in vivo and in vitro.</p></sec><sec id="Sec8" sec-type="methods"><title>Methods</title><sec id="Sec9"><title>Bioinformatics analysis, plasmid construction and cloning methodology</title><p id="Par20">In order to the construct fusion gene, the full length of HBHA HBHA-coding sequence (KC920678) which encodes adhesive part of chimeric protein was selected. Searching the full length of FAP-P (KF021287) for distinguishing high antigenic region was done using CLC software (main workbench 5.5). Eventually, one type of rigid linker between these two corresponding genes was determined in such a way that the 3D structure of HBHA was similar to its native form using TM-align (<ext-link xlink:href="http://zhanglab.ccmb.med.umich.edu/TM-align" ext-link-type="url">http://zhanglab.ccmb.med.umich.edu/TM-align</ext-link>). The final fusion gene was synthesized and inserted in pUC57 between restriction sites of <italic>Eco</italic>RI and <italic>Hin</italic>dIII by GenScript Company (USA).</p><p id="Par21"><italic>Escherichia coli</italic> DH5α was grown at 37 °C in Luria–Bertani medium (Himedia, India) for the cloning procedure. Chemical transformation of pUC57HBHA-FAP into <italic>E. coli</italic> DH5α strain was done and recombinant transformants were selected by culturing on the LB medium supplemented with 50 μg/ml ampicillin. Subcloning of the fusion gene was done by digesting plasmid with <italic>Eco</italic>RI and <italic>Hin</italic>dIII (Roche, Germany), and ligating downstream of the T7 promoter into recipient expression vector of pET-26b(+). The ligation mixture was transformed into <italic>E. coli</italic> BL21 (DE3) and eventually, colony PCR and enzymatic digestion confirmed the presence and proper orientation of the target DNA insert in plasmid construct. For negative control, the parent pET26b without insert was also transformed similarly.</p></sec><sec id="Sec10"><title>Expression and purification of rHBHA-FAP</title><p id="Par22">The overnight broth culture of recombinant colonies was inoculated into 200 ml of fresh LB medium (1:100) and the culture was shaken (150×<italic>g</italic>) until the OD<sub>600</sub> value reached 0.6. Then, three IPTG concentrations ranging from 0.5 to 10 mM (0.5, 1 and 10 mM), and two temperatures (30 °C and 37 °C), were tried in order to choose the optimum situation for expression.</p><p id="Par23">Culture pellets were collected at different time points ranging from 0 to 24 h (0 h, 1 h, 2 h, 4 h and 24 h).</p><p id="Par24">The pellets were lysed by 50 μl 2× sample buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromphenol blue and 0.125 M Tris HCl, pH approx. 6.8), heated at 90 °C for 10 min and analyzed by running them on 12% polyacrylamide gel electrophoresis under denaturing condition and were subsequently stained with Coomassie Brilliant Blue R-250 (Merck, Germany).</p><p id="Par25">By using western blot, the fusion protein was identified based on expressed histidine tag. Hence, the SDS-PAGE separated proteins were transferred onto a nitrocellulose membrane and incubated with a 1:10,000 dilution of monoclonal anti-polyhistidine-peroxidase (Sigma, USA). The color development was done by using H<sub>2</sub>O<sub>2</sub>/DAB substrate/chromogen (Sigma, USA).</p><p id="Par26">The conserved pelleted cells in − 20 °C were resuspended in 700 µl lysis buffer containing 7 M urea, 0.1 M sodium phosphate, and 0.01 M Tric HCl at a final pH of 8, and 1 mM proteinase inhibitor of Phenylmethanesulfonyl fluoride (Sigma, USA). The mixture was incubated at room temperature (RT) for 15 min and then insoluble debris was removed by centrifugation at 13,000<italic>g</italic> for 30 min at room temperature. The supernatant was added to pre-equilibrated Ni–NTA spin columns (Qiagen, Germany) and then centrifuged at 270<italic>g</italic> for 10 min. The wash procedure was done three times with 600 µl wash buffer containing 8 M urea, 0.1 M sodium phosphate, 0.01 M Tris.Cl, 20 mM imidazole, 2% Tween and 20 mM β-mercaptoethanol at pH of 6.3. The recombinant fusion protein was then eluted from the resin by adding 200 µl elution buffer (8 M urea, 0.1 M sodium phosphate, 0.01 M Tris.Cl and 100 mM imidazole at pH 4.5) and centrifuged at 890<italic>g</italic> for 2 min. To obtain soluble recombinant fusion protein and for removing urea, the collected fractions were dialyzed against four changes in PBS over the period of 36 h. Protein concentration was determined using the Bradford assay.</p></sec><sec id="Sec11"><title>Animals and immunization</title><p id="Par27">Prior to the experiment, goats aged 12 months were obtained from a local farm. Fecal samples before the immunization experiments were negative for <italic>M. avium</italic> subsp. <italic>paratuberculosis</italic> by PCR targeting IS<italic>900</italic> gene. Three goats were immunized five times, subcutaneously in the neck, at 1-week intervals, using a volume of 1 ml of one of the following: 0.5 ml purified protein derivative (350 µg) (PPD-the crude protein fraction prepared from the culture supernatant of MAP) mixed 1:1 (v/v) with Quil A (2 mg/ml) for positive control, 0.5 ml distilled water mixed 1:1 (v/v) with the same adjuvant for negative control, and 200 µg of chimeric protein with the same adjuvant for test. Immunization and bleeding schedule are presented in Table <xref rid="Tab1" ref-type="table">1</xref>. Immunization of goats with PPD was done to create memory T cell against all proteins of MAP to check the response and level of secreted IFN-γ against rHBHA-FAP.<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Schedule for vaccination and bleeding of goats</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Time post-primary vaccination (weeks)</p></th><th align="left"><p>Procedure conducted</p></th></tr></thead><tbody><tr><td align="left"><p>0</p></td><td align="left"><p>Vaccination, bleeding (5 ml, jugular vein)</p></td></tr><tr><td align="left"><p>1</p></td><td align="left"><p>Booster vaccination</p></td></tr><tr><td align="left"><p>2</p></td><td align="left"><p>Booster vaccination, bleeding (5 ml, jugular vein)</p></td></tr><tr><td align="left"><p>3</p></td><td align="left"><p>Booster vaccination, bleeding (5 ml, jugular vein)</p></td></tr><tr><td align="left"><p>4</p></td><td align="left"><p>Booster vaccination, bleeding (5 ml, jugular vein)</p></td></tr><tr><td align="left"><p>5</p></td><td align="left"><p>Booster vaccination, bleeding (5 ml, jugular vein)</p></td></tr><tr><td align="left"><p>6</p></td><td align="left"><p>Bleeding (5 ml, jugular vein)</p></td></tr></tbody></table></table-wrap></p><p id="Par28">After the experiment, all animals were transferred to animal house of school of veterinary medicine, Shiraz University.</p></sec><sec id="Sec12"><title>Primary cell cultures and IFN-γ assay</title><p id="Par29">To obtain PBMC, based on the schedule (Table <xref rid="Tab1" ref-type="table">1</xref>), blood samples were taken from all goats (three samples from each group). Samples were diluted 1:1 with Ca<sup>2+</sup> and Mg<sup>2+</sup> free phosphate-buffered saline (PBS) and centrifuged (at 1000×<italic>g</italic> and 20 °C for 25 min). Diluted leukocytes with PBS (1:1) were layered onto Lymphodex (Inno-Train, Germany), and centrifuged (at 800×<italic>g</italic> and 18 °C for 25 min). PBMCs were recovered from the buffer interface and erythrocytes were removed by incubating the cell suspension with RBC lysis buffer for 10 min at RT. Afterward, the cells were washed twice with PBS and resuspended in RPMI 1640 (GIBCO) supplemented with 10% fetal calf serum, 50 µM 2-mercaptoethanol, 1 mM sodium pyruvate, 100 µg/ml Streptomycin, and 50 µg/ml Gentamycin. Finally, 200 µl of cell suspension containing 450,000 cells was seeded onto 96-well flat-bottom plates.</p><p id="Par30">PBMCs isolated from immunized goats of positive control (vaccinated with PPD), and negative control (vaccinated with adjuvant), and test (vaccinated with the chimeric protein) at various time points were stimulated either with chimeric protein (10 μg/ml), PPD (10 μg/ml), or a selective T cell mitogen (2% phytohaemagglutinin (PHA), GIBCO) in triplicates. For negative control in cell culture, the same condition of cultured cells without any stimulation was considered. Plates were incubated in 5% CO<sub>2</sub> at 37 °C. Gamma interferon (IFN-γ) levels were measured in PBMC cell-free culture supernatant using commercially available ID Screen Ruminant Interferon Gamma Kit (IDvet Kit, France) in time points of 48, 72, and 96 h after incubation by the standard ELISA technique and according to the manufacturer’s instructions. The plates were read at 450 nm for optical densities using microplate reader. As a linear curve (log–log), standard curves for IFN-γ, ranging from 0.25 to 1 ng/ml, were constructed and cytokine concentrations of experimental samples were determined.</p></sec><sec id="Sec13"><title>Statistical analysis</title><p id="Par31">All replicates for each group were combined to develop a mean response and error measurements were made using the standard error of the mean method. Comparisons between individual groups at each analysis time point were made using Mann–Whitney test and the p-value of &lt; 0.05 was taken as statistically significant.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>The authors would like to thank Dr. Mostafavi for his friendly assistance during the project and the lab technicians, especially Mr. M. R. Sorbi who helped us as the instruments operator.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>VE: conceptualization, data curation, formal analysis, investigation, methodology, project administration, software, visualization and writing the manuscript. AD: conceptualization, funding acquisition, investigation, methodology, project administration, resources, supervision, validation, visualization, revising the manuscript. AH: conceptualization, funding acquisition, investigation, methodology, project administration, resources, supervision, validation, visualization. MH: conceptualization, methodology, resources, supervision, validation. LAS: conceptualization, funding acquisition, methodology, resources, supervision, validation, revising the manuscript. AMB: conceptualization, data curation, investigation, methodology, visualization. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>This study was funded by School of Veterinary Science, Shiraz University.</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The authors confirmed that all data are fully available without restriction and all relevant data are within the paper.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par32">The experiment was carried out in strict accordance with the guidelines of the Animal Ethics Committee of School of Veterinary Medicine, Shiraz University (dated 20 September 2013) and all applicable guidelines for the care and use of animals were followed (Permit No: 93GCU2M163973).</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par33">All authors give final approval of the version to be submitted in Gut Pathogens journal.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par34">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faisal</surname><given-names>SM</given-names></name><name><surname>Chen</surname><given-names>J-W</given-names></name><name><surname>Yan</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>T-T</given-names></name><name><surname>Useh</surname><given-names>NM</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><etal/></person-group><article-title xml:lang="en">Evaluation of a <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> leuD mutant as a vaccine candidate against challenge in a caprine model</article-title><source>Clin Vaccine Immunol</source><year>2013</year><volume>20</volume><issue>4</issue><fpage>572</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">23408524</pub-id><pub-id pub-id-type="pmcid">3623397</pub-id><pub-id pub-id-type="doi">10.1128/CVI.00653-12</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurung</surname><given-names>RB</given-names></name><name><surname>Purdie</surname><given-names>AC</given-names></name><name><surname>Begg</surname><given-names>DJ</given-names></name><name><surname>Whittington</surname><given-names>RJ</given-names></name></person-group><article-title xml:lang="en">In silico screened <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> (MAP) recombinant proteins upregulated under stress conditions are immunogenic in sheep</article-title><source>Vet Immunol Immunopathol</source><year>2012</year><volume>149</volume><issue>3</issue><fpage>186</fpage><lpage>196</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtFGrtL3J</pub-id><pub-id pub-id-type="pmid">22868202</pub-id><pub-id pub-id-type="doi">10.1016/j.vetimm.2012.06.026</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellingson</surname><given-names>JL</given-names></name><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>Koziczkowski</surname><given-names>JJ</given-names></name><name><surname>Radcliff</surname><given-names>RP</given-names></name><name><surname>Sloan</surname><given-names>SJ</given-names></name><name><surname>Allen</surname><given-names>SE</given-names></name><etal/></person-group><article-title xml:lang="en">Detection of viable <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> in retail pasteurized whole milk by two culture methods and PCR</article-title><source>J Food Prot</source><year>2005</year><volume>68</volume><issue>5</issue><fpage>966</fpage><lpage>972</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXkslynuro%3D</pub-id><pub-id pub-id-type="pmid">15895728</pub-id><pub-id pub-id-type="doi">10.4315/0362-028X-68.5.966</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hruska</surname><given-names>K</given-names></name><name><surname>Bartos</surname><given-names>M</given-names></name><name><surname>Kralik</surname><given-names>P</given-names></name><name><surname>Pavlik</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> in powdered infant milk: paratuberculosis in cattle-the public health problem to be solved</article-title><source>Vet Med Praha</source><year>2005</year><volume>50</volume><issue>8</issue><fpage>327</fpage><pub-id pub-id-type="doi">10.17221/5631-VETMED</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sechi</surname><given-names>LA</given-names></name><name><surname>Dow</surname><given-names>CT</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium avium</italic> ss. <italic>paratuberculosis</italic> zoonosis—the hundred year war–beyond Crohn’s disease</article-title><source>Front Immunol</source><year>2015</year><volume>6</volume><fpage>96</fpage><pub-id pub-id-type="pmid">25788897</pub-id><pub-id pub-id-type="pmcid">4349160</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2015.00096</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzone</surname><given-names>P</given-names></name><name><surname>Corneli</surname><given-names>S</given-names></name><name><surname>Di Paolo</surname><given-names>A</given-names></name><name><surname>Maresca</surname><given-names>C</given-names></name><name><surname>Felici</surname><given-names>A</given-names></name><name><surname>Biagetti</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Survival of <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> in the intermediate and final digestion products of biogas plants</article-title><source>J Appl Microbiol</source><year>2018</year><volume>125</volume><issue>1</issue><fpage>36</fpage><lpage>44</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhtFKhtLfI</pub-id><pub-id pub-id-type="pmid">29573309</pub-id><pub-id pub-id-type="doi">10.1111/jam.13762</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkwood</surname><given-names>CD</given-names></name><name><surname>Wagner</surname><given-names>J</given-names></name><name><surname>Boniface</surname><given-names>K</given-names></name><name><surname>Vaughan</surname><given-names>J</given-names></name><name><surname>Michalski</surname><given-names>WP</given-names></name><name><surname>Catto-Smith</surname><given-names>AG</given-names></name><etal/></person-group><article-title xml:lang="en">Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn’s disease</article-title><source>Inflamm Bowel Dis</source><year>2009</year><volume>15</volume><issue>11</issue><fpage>1643</fpage><lpage>1655</lpage><pub-id pub-id-type="pmid">19462429</pub-id><pub-id pub-id-type="doi">10.1002/ibd.20967</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dow</surname><given-names>CT</given-names></name><name><surname>Ellingson</surname><given-names>JL</given-names></name></person-group><article-title xml:lang="en">Detection of <italic>Mycobacterium avium</italic> ss. <italic>paratuberculosis</italic> in Blau syndrome tissues</article-title><source>Autoimmune Dis</source><year>2010</year><volume>2011</volume><fpage>127692</fpage><pub-id pub-id-type="pmid">21152214</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossu</surname><given-names>A</given-names></name><name><surname>Rosu</surname><given-names>V</given-names></name><name><surname>Paccagnini</surname><given-names>D</given-names></name><name><surname>Cossu</surname><given-names>D</given-names></name><name><surname>Pacifico</surname><given-names>A</given-names></name><name><surname>Sechi</surname><given-names>LA</given-names></name></person-group><article-title xml:lang="en">MAP3738c and MptD are specific tags of <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> infection in type I diabetes mellitus</article-title><source>Clin Immunol</source><year>2011</year><volume>141</volume><issue>1</issue><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXht1ansbrJ</pub-id><pub-id pub-id-type="pmid">21664191</pub-id><pub-id pub-id-type="doi">10.1016/j.clim.2011.05.002</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinna</surname><given-names>A</given-names></name><name><surname>Masala</surname><given-names>S</given-names></name><name><surname>Blasetti</surname><given-names>F</given-names></name><name><surname>Maiore</surname><given-names>I</given-names></name><name><surname>Cossu</surname><given-names>D</given-names></name><name><surname>Paccagnini</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Detection of serum antibodies cross-reacting with <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> and beta-cell antigen zinc transporter 8 homologous peptides in patients with high-risk proliferative diabetic retinopathy</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>9</issue><fpage>e107802</fpage><pub-id pub-id-type="pmid">25226393</pub-id><pub-id pub-id-type="pmcid">4166466</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0107802</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossu</surname><given-names>D</given-names></name><name><surname>Cocco</surname><given-names>E</given-names></name><name><surname>Paccagnini</surname><given-names>D</given-names></name><name><surname>Masala</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>N</given-names></name><name><surname>Frau</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Association of <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> with multiple sclerosis in Sardinian patients</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><issue>4</issue><fpage>e18482</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXltV2rtbw%3D</pub-id><pub-id pub-id-type="pmid">21533236</pub-id><pub-id pub-id-type="pmcid">3076380</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0018482</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H-T</given-names></name><name><surname>Yoo</surname><given-names>HS</given-names></name></person-group><article-title xml:lang="en">Development of vaccines to <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> infection</article-title><source>Clin Exp Vacc Res</source><year>2016</year><volume>5</volume><issue>2</issue><fpage>108</fpage><lpage>116</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXosVyjtbg%3D</pub-id><pub-id pub-id-type="doi">10.7774/cevr.2016.5.2.108</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juste</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Slow infection control by vaccination: paratuberculosis</article-title><source>Vet Immunol Immunopathol</source><year>2012</year><volume>148</volume><issue>1</issue><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">22698388</pub-id><pub-id pub-id-type="doi">10.1016/j.vetimm.2012.05.017</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannantine</surname><given-names>JP</given-names></name><name><surname>Bermudez</surname><given-names>LE</given-names></name></person-group><article-title xml:lang="en">No holes barred: invasion of the intestinal mucosa by <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic></article-title><source>Infect Immun</source><year>2013</year><volume>81</volume><issue>11</issue><fpage>3960</fpage><lpage>3965</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhs1Kjtb7M</pub-id><pub-id pub-id-type="pmid">23940208</pub-id><pub-id pub-id-type="pmcid">3811823</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00575-13</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganusov</surname><given-names>VV</given-names></name><name><surname>Klinkenberg</surname><given-names>D</given-names></name><name><surname>Bakker</surname><given-names>D</given-names></name><name><surname>Koets</surname><given-names>AP</given-names></name></person-group><article-title xml:lang="en">Evaluating contribution of the cellular and humoral immune responses to the control of shedding of <italic>Mycobacterium avium</italic> spp. <italic>paratuberculosis</italic> in cattle</article-title><source>Vet Res.</source><year>2015</year><volume>46</volume><issue>1</issue><fpage>62</fpage><pub-id pub-id-type="pmid">26092254</pub-id><pub-id pub-id-type="pmcid">4474352</pub-id><pub-id pub-id-type="doi">10.1186/s13567-015-0204-1</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>RW</given-names></name></person-group><article-title xml:lang="en">Pathogenesis of paratuberculosis</article-title><source>Vet Clin North Am</source><year>2011</year><volume>27</volume><issue>3</issue><fpage>537</fpage><lpage>546</lpage></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coussens</surname><given-names>PM</given-names></name><name><surname>Colvin</surname><given-names>CJ</given-names></name><name><surname>Wiersma</surname><given-names>K</given-names></name><name><surname>Abouzied</surname><given-names>A</given-names></name><name><surname>Sipkovsky</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Gene expression profiling of peripheral blood mononuclear cells from cattle infected with <italic>Mycobacterium paratuberculosis</italic></article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><issue>10</issue><fpage>5494</fpage><lpage>5502</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XnsV2ls7s%3D</pub-id><pub-id pub-id-type="pmid">12228275</pub-id><pub-id pub-id-type="pmcid">128350</pub-id><pub-id pub-id-type="doi">10.1128/IAI.70.10.5494-5502.2002</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koets</surname><given-names>A</given-names></name><name><surname>Rutten</surname><given-names>V</given-names></name><name><surname>Hoek</surname><given-names>A</given-names></name><name><surname>van Mil</surname><given-names>F</given-names></name><name><surname>Müller</surname><given-names>K</given-names></name><name><surname>Bakker</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Progressive bovine paratuberculosis is associated with local loss of CD4+ T cells, increased frequency of γδ T cells, and related changes in T-cell function</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><issue>7</issue><fpage>3856</fpage><lpage>3864</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XkvV2ksb4%3D</pub-id><pub-id pub-id-type="pmid">12065529</pub-id><pub-id pub-id-type="pmcid">128076</pub-id><pub-id pub-id-type="doi">10.1128/IAI.70.7.3856-3864.2002</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannantine</surname><given-names>JP</given-names></name><name><surname>Huntley</surname><given-names>JF</given-names></name><name><surname>Miltner</surname><given-names>E</given-names></name><name><surname>Stabel</surname><given-names>JR</given-names></name><name><surname>Bermudez</surname><given-names>LE</given-names></name></person-group><article-title xml:lang="en">The <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> 35 kDa protein plays a role in invasion of bovine epithelial cells</article-title><source>Microbiology</source><year>2003</year><volume>149</volume><issue>8</issue><fpage>2061</fpage><lpage>2069</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXmslaqsLg%3D</pub-id><pub-id pub-id-type="pmid">12904546</pub-id><pub-id pub-id-type="doi">10.1099/mic.0.26323-0</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masungi</surname><given-names>C</given-names></name><name><surname>Temmerman</surname><given-names>S</given-names></name><name><surname>Van Vooren</surname><given-names>J-P</given-names></name><name><surname>Drowart</surname><given-names>A</given-names></name><name><surname>Pethe</surname><given-names>K</given-names></name><name><surname>Menozzi</surname><given-names>FD</given-names></name><etal/></person-group><article-title xml:lang="en">Differential T and B cell responses against <italic>Mycobacterium tuberculosis</italic> heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis</article-title><source>J Infect Dis</source><year>2002</year><volume>185</volume><issue>4</issue><fpage>513</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">11865404</pub-id><pub-id pub-id-type="doi">10.1086/338833</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>M</given-names></name><name><surname>Pickett</surname><given-names>T</given-names></name><name><surname>Delogu</surname><given-names>G</given-names></name><name><surname>Dheenadhayalan</surname><given-names>V</given-names></name><name><surname>Debrie</surname><given-names>A-S</given-names></name><name><surname>Locht</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis</article-title><source>Infect Immun</source><year>2004</year><volume>72</volume><issue>12</issue><fpage>6799</fpage><lpage>6805</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXhtVGls7%2FM</pub-id><pub-id pub-id-type="pmid">15557600</pub-id><pub-id pub-id-type="pmcid">529156</pub-id><pub-id pub-id-type="doi">10.1128/IAI.72.12.6799-6805.2004</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aerts</surname><given-names>L</given-names></name><name><surname>Selis</surname><given-names>E</given-names></name><name><surname>Corbière</surname><given-names>V</given-names></name><name><surname>Smits</surname><given-names>K</given-names></name><name><surname>Van Praet</surname><given-names>A</given-names></name><name><surname>Dauby</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">HBHA-induced polycytotoxic CD4<sup>+</sup> T lymphocytes are associated with the control of <italic>Mycobacterium tuberculosis</italic> infection in humans</article-title><source>J Immunol</source><year>2019</year><volume>202</volume><issue>2</issue><fpage>421</fpage><lpage>427</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXitFKlur4%3D</pub-id><pub-id pub-id-type="pmid">30559320</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1800840</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temmerman</surname><given-names>S</given-names></name><name><surname>Pethe</surname><given-names>K</given-names></name><name><surname>Parra</surname><given-names>M</given-names></name><name><surname>Alonso</surname><given-names>S</given-names></name><name><surname>Rouanet</surname><given-names>C</given-names></name><name><surname>Pickett</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Methylation-dependent T cell immunity to <italic>Mycobacterium tuberculosis</italic> heparin-binding hemagglutinin</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><issue>9</issue><fpage>935</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXntFSkt70%3D</pub-id><pub-id pub-id-type="pmid">15300244</pub-id><pub-id pub-id-type="doi">10.1038/nm1090</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Shin</surname><given-names>SJ</given-names></name><name><surname>Collins</surname><given-names>MT</given-names></name><name><surname>Jung</surname><given-names>ID</given-names></name><name><surname>Jeong</surname><given-names>Y-I</given-names></name><name><surname>Lee</surname><given-names>C-M</given-names></name><etal/></person-group><article-title xml:lang="en"><italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> fibronectin attachment protein activates dendritic cells and induces a Th1 polarization</article-title><source>Infect Immun</source><year>2009</year><volume>77</volume><issue>7</issue><fpage>2979</fpage><lpage>2988</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXotFamt7s%3D</pub-id><pub-id pub-id-type="pmid">19398539</pub-id><pub-id pub-id-type="pmcid">2708578</pub-id><pub-id pub-id-type="doi">10.1128/IAI.01411-08</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raupach</surname><given-names>B</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title xml:lang="en">Immune responses to intracellular bacteria</article-title><source>Curr Opin Immunol</source><year>2001</year><volume>13</volume><issue>4</issue><fpage>417</fpage><lpage>428</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXltVGlu7o%3D</pub-id><pub-id pub-id-type="pmid">11498297</pub-id><pub-id pub-id-type="doi">10.1016/S0952-7915(00)00236-3</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huntley</surname><given-names>JF</given-names></name><name><surname>Stabel</surname><given-names>JR</given-names></name><name><surname>Bannantine</surname><given-names>JP</given-names></name></person-group><article-title xml:lang="en">Immunoreactivity of the <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> 19-kDa lipoprotein</article-title><source>BMC Microbiol</source><year>2005</year><volume>5</volume><issue>1</issue><fpage>3</fpage><pub-id pub-id-type="pmid">15663791</pub-id><pub-id pub-id-type="pmcid">548131</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-5-3</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathaperumal</surname><given-names>K</given-names></name><name><surname>Kumanan</surname><given-names>V</given-names></name><name><surname>McDonough</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>L-H</given-names></name><name><surname>Park</surname><given-names>S-U</given-names></name><name><surname>Moreira</surname><given-names>MA</given-names></name><etal/></person-group><article-title xml:lang="en">Evaluation of immune responses and protective efficacy in a goat model following immunization with a cocktail of recombinant antigens and a polyprotein of <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic></article-title><source>Vaccine.</source><year>2009</year><volume>27</volume><issue>1</issue><fpage>123</fpage><lpage>135</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhsVersLfL</pub-id><pub-id pub-id-type="pmid">18955101</pub-id><pub-id pub-id-type="doi">10.1016/j.vaccine.2008.10.019</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koets</surname><given-names>A</given-names></name><name><surname>Rutten</surname><given-names>V</given-names></name><name><surname>Hoek</surname><given-names>A</given-names></name><name><surname>Bakker</surname><given-names>D</given-names></name><name><surname>Van Zijderveld</surname><given-names>F</given-names></name><name><surname>Müller</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Heat-shock protein-specific T-cell responses in various stages of bovine paratuberculosis</article-title><source>Vet Immunol Immunopathol</source><year>1999</year><volume>70</volume><issue>1</issue><fpage>105</fpage><lpage>115</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1MXmtVGntbs%3D</pub-id><pub-id pub-id-type="pmid">10507291</pub-id><pub-id pub-id-type="doi">10.1016/S0165-2427(99)00062-8</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>R</given-names></name><name><surname>Muneta</surname><given-names>Y</given-names></name><name><surname>Yoshihara</surname><given-names>K</given-names></name><name><surname>Yokomizo</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Expression cloning of gamma interferon-inducing antigens of <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic></article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><issue>6</issue><fpage>3778</fpage><lpage>3782</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXkvFCntrg%3D</pub-id><pub-id pub-id-type="pmid">15908411</pub-id><pub-id pub-id-type="pmcid">1111817</pub-id><pub-id pub-id-type="doi">10.1128/IAI.73.6.3778-3782.2005</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>I</given-names></name><name><surname>Reitan</surname><given-names>LJ</given-names></name><name><surname>Holstad</surname><given-names>G</given-names></name><name><surname>Wiker</surname><given-names>HG</given-names></name></person-group><article-title xml:lang="en">Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic></article-title><source>Infect Immun</source><year>2000</year><volume>68</volume><issue>2</issue><fpage>801</fpage><lpage>808</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3cXotFOkug%3D%3D</pub-id><pub-id pub-id-type="pmid">10639449</pub-id><pub-id pub-id-type="pmcid">97208</pub-id><pub-id pub-id-type="doi">10.1128/IAI.68.2.801-808.2000</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigden</surname><given-names>RC</given-names></name><name><surname>Jandhyala</surname><given-names>DM</given-names></name><name><surname>Dupont</surname><given-names>C</given-names></name><name><surname>Crosbie-Caird</surname><given-names>D</given-names></name><name><surname>Lopez-Villalobos</surname><given-names>N</given-names></name><name><surname>Maeda</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Humoral and cellular immune responses in sheep immunized with a 22 kilodalton exported protein of <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic></article-title><source>J Med Microbiol</source><year>2006</year><volume>55</volume><issue>12</issue><fpage>1735</fpage><lpage>1740</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXislGrtg%3D%3D</pub-id><pub-id pub-id-type="pmid">17108279</pub-id><pub-id pub-id-type="doi">10.1099/jmm.0.46785-0</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>SJ</given-names></name><name><surname>Chang</surname><given-names>C-F</given-names></name><name><surname>Chang</surname><given-names>C-D</given-names></name><name><surname>McDonough</surname><given-names>SP</given-names></name><name><surname>Thompson</surname><given-names>B</given-names></name><name><surname>Yoo</surname><given-names>HS</given-names></name><etal/></person-group><article-title xml:lang="en">In vitro cellular immune responses to recombinant antigens of <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic></article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><issue>8</issue><fpage>5074</fpage><lpage>5085</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXmvVCisLg%3D</pub-id><pub-id pub-id-type="pmid">16041023</pub-id><pub-id pub-id-type="pmcid">1201233</pub-id><pub-id pub-id-type="doi">10.1128/IAI.73.8.5074-5085.2005</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>I</given-names></name><name><surname>Storset</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Innate IFN-γ production in cattle in response to MPP14, a secreted protein from <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic></article-title><source>Scand J Immunol</source><year>2001</year><volume>54</volume><issue>3</issue><fpage>306</fpage><lpage>313</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXnt1Sqsrg%3D</pub-id><pub-id pub-id-type="pmid">11555395</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-3083.2001.00954.x</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burrells</surname><given-names>C</given-names></name><name><surname>Inglis</surname><given-names>N</given-names></name><name><surname>Davies</surname><given-names>R</given-names></name><name><surname>Sharp</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Detection of specific T cell reactivity in sheep infected with <italic>Mycobacterium avium</italic> subspecies <italic>silvaticum</italic> and <italic>paratuberculosis</italic> using two defined mycobacterial antigens</article-title><source>Vet Immunol Immunopathol</source><year>1995</year><volume>45</volume><issue>3</issue><fpage>311</fpage><lpage>320</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2MvgslSktQ%3D%3D</pub-id><pub-id pub-id-type="pmid">7545852</pub-id><pub-id pub-id-type="doi">10.1016/0165-2427(94)05347-U</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullerad</surname><given-names>J</given-names></name><name><surname>Hovav</surname><given-names>A-H</given-names></name><name><surname>Fishman</surname><given-names>Y</given-names></name><name><surname>Barletta</surname><given-names>RG</given-names></name><name><surname>Bercovier</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Antigenicity of <italic>Mycobacterium paratuberculosis</italic> superoxide dismutase in mice</article-title><source>FEMS Immunol Med Microbiol</source><year>2002</year><volume>34</volume><issue>1</issue><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38Xms12hurY%3D</pub-id><pub-id pub-id-type="pmid">12208610</pub-id><pub-id pub-id-type="doi">10.1111/j.1574-695X.2002.tb00606.x</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullerad</surname><given-names>J</given-names></name><name><surname>Michal</surname><given-names>I</given-names></name><name><surname>Fishman</surname><given-names>Y</given-names></name><name><surname>Hovav</surname><given-names>A-H</given-names></name><name><surname>Barletta</surname><given-names>RG</given-names></name><name><surname>Bercovier</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">The immunogenicity of <italic>Mycobacterium paratuberculosis</italic> 85B antigen</article-title><source>Med Microbiol Immunol</source><year>2002</year><volume>190</volume><issue>4</issue><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38Xhs1yqtLc%3D</pub-id><pub-id pub-id-type="pmid">12005331</pub-id><pub-id pub-id-type="doi">10.1007/s00430-001-0104-z</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullerad</surname><given-names>J</given-names></name><name><surname>Hovav</surname><given-names>A-H</given-names></name><name><surname>Nahary</surname><given-names>R</given-names></name><name><surname>Fishman</surname><given-names>Y</given-names></name><name><surname>Bercovier</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Immunogenicity of a 16.7 kDa <italic>Mycobacterium paratuberculosis</italic> antigen</article-title><source>Microb Pathog</source><year>2003</year><volume>34</volume><issue>2</issue><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXhs1KnsrY%3D</pub-id><pub-id pub-id-type="pmid">12623276</pub-id><pub-id pub-id-type="doi">10.1016/S0882-4010(02)00209-7</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Noh</surname><given-names>KT</given-names></name><name><surname>Kang</surname><given-names>TH</given-names></name><name><surname>Han</surname><given-names>HD</given-names></name><name><surname>Shin</surname><given-names>SJ</given-names></name><name><surname>Soh</surname><given-names>BY</given-names></name><etal/></person-group><article-title xml:lang="en">The <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4</article-title><source>BMB Rep</source><year>2014</year><volume>47</volume><issue>2</issue><fpage>115</fpage><pub-id pub-id-type="pmid">24393523</pub-id><pub-id pub-id-type="pmcid">4163902</pub-id><pub-id pub-id-type="doi">10.5483/BMBRep.2014.47.2.277</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosseels</surname><given-names>V</given-names></name><name><surname>Marché</surname><given-names>S</given-names></name><name><surname>Roupie</surname><given-names>V</given-names></name><name><surname>Govaerts</surname><given-names>M</given-names></name><name><surname>Godfroid</surname><given-names>J</given-names></name><name><surname>Walravens</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Members of the 30-to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic> are immunodominant Th1-type antigens recognized early upon infection in mice and cattle</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><issue>1</issue><fpage>202</fpage><lpage>212</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XitlKnsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">16368974</pub-id><pub-id pub-id-type="pmcid">1346609</pub-id><pub-id pub-id-type="doi">10.1128/IAI.74.1.202-212.2006</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byun</surname><given-names>E-H</given-names></name><name><surname>Kim</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>J-S</given-names></name><name><surname>Won</surname><given-names>C-J</given-names></name><name><surname>Choi</surname><given-names>H-G</given-names></name><name><surname>Kim</surname><given-names>H-J</given-names></name><etal/></person-group><article-title xml:lang="en"><italic>Mycobacterium paratuberculosis</italic> CobT activates dendritic cells via engagement of Toll-like receptor 4 resulting in Th1 cell expansion</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><issue>46</issue><fpage>38609</fpage><lpage>38624</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xhs1ektbrK</pub-id><pub-id pub-id-type="pmid">23019321</pub-id><pub-id pub-id-type="pmcid">3493906</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M112.391060</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoek</surname><given-names>A</given-names></name><name><surname>Rutten</surname><given-names>VP</given-names></name><name><surname>Vander Zee</surname><given-names>R</given-names></name><name><surname>Davies</surname><given-names>CJ</given-names></name><name><surname>Koets</surname><given-names>AP</given-names></name></person-group><article-title xml:lang="en">Epitopes of <italic>Mycobacterium avium</italic> ssp. <italic>paratuberculosis</italic> 70 kDa heat-shock protein activate bovine helper T cells in outbred cattle</article-title><source>Vaccine.</source><year>2010</year><volume>28</volume><issue>36</issue><fpage>5910</fpage><lpage>5919</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtVaqurfE</pub-id><pub-id pub-id-type="pmid">20600507</pub-id><pub-id pub-id-type="doi">10.1016/j.vaccine.2010.06.042</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>WS</given-names></name><name><surname>Shin</surname><given-names>M-K</given-names></name><name><surname>Shin</surname><given-names>SJ</given-names></name></person-group><article-title xml:lang="en">MAP1981c, a putative nucleic acid-binding protein, produced by <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic>, induces maturation of dendritic cells and Th1-polarization</article-title><source>Front Cell Infect Microbiol</source><year>2018</year><volume>8</volume><fpage>206</fpage><pub-id pub-id-type="pmid">29977867</pub-id><pub-id pub-id-type="pmcid">6021526</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2018.00206</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holsti</surname><given-names>MA</given-names></name><name><surname>Schorey</surname><given-names>JS</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name></person-group><article-title xml:lang="en">Identification of epitopes of fibronectin attachment protein (FAP-A) of <italic>Mycobacterium avium</italic> which stimulate strong T-cell responses in mice</article-title><source>Infect Immun</source><year>1998</year><volume>66</volume><issue>3</issue><fpage>1261</fpage><lpage>1264</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXhtlSrs7o%3D</pub-id><pub-id pub-id-type="pmid">9488424</pub-id><pub-id pub-id-type="pmcid">108044</pub-id></mixed-citation></ref></ref-list></ref-list><notes notes-type="Misc"><title>Publisher's Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Gastroenterology</facet-value><facet-value count="1">Medical Microbiology</facet-value><facet-value count="1">Medicine &amp; Public Health</facet-value><facet-value count="1">Parasitology</facet-value></facet><facet name="keyword"><facet-value count="1">
                        Mycobacterium avium subsp. paratuberculosis
                     </facet-value><facet-value count="1">Chimeric protein</facet-value><facet-value count="1">IFN-γ</facet-value><facet-value count="1">Johne’s disease</facet-value><facet-value count="1">PBMC</facet-value></facet><facet name="pub"><facet-value count="1">Gut Pathogens</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Iran</facet-value><facet-value count="1">Italy</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
